Your session is about to expire
← Back to Search
Natural Product
Açaí palm berry extract - natural product for Coronavirus Disease (ACAI Trial)
Phase 2
Waitlist Available
Led By Ana Andreazza, PhD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
ACAI Trial Summary
This trial will test if the açaí berry extract can be used as a treatment option for adult patients with COVID-19.
ACAI Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
7-point ordinal symptom scale
Secondary outcome measures
All-cause mortality
Need for hospitalization
Need for mechanical ventilation
+2 moreACAI Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Açaí palm berry extractExperimental Treatment1 Intervention
Açaí palm berry extract is a powerful antioxidant with no known side-effects and is widely consumed in Brazil. Açaí palm berry chemical composition has been established and includes several antioxidants - gallic acid, catechin, chlorogenic acid, caffeic acid, p-coumaric acid, epicatechin, orientin, cyanidin-3-0-glucoside, luteolin and apigenin. Orientin is the most concentrated compound (7,96mg/g) and this compound is able to modulate the NLRP3 inflammasome.
Group II: Placebo armPlacebo Group1 Intervention
This study will be double-blinded and placebo-controlled. To ensure double-blinding, placebo and active compound capsules will be over-encapsulated with DBCAPS® capsules, which were developed with a tamper-evident design to address the clinical trial challenges of testing without bias. These capsules are made of gelatin and have no interaction with bioavailability.
Find a Location
Who is running the clinical trial?
University of TorontoOTHER
688 Previous Clinical Trials
1,018,070 Total Patients Enrolled
University Health Network, TorontoLead Sponsor
1,465 Previous Clinical Trials
483,209 Total Patients Enrolled
Ana Andreazza, PhDPrincipal InvestigatorDepartment of Pharmacology & Toxicology; University of Toronto
1 Previous Clinical Trials
54 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is Açaí palm berry extract a safe and reliable treatment option?
"Açaí palm berry extract - natural product has not been proven effective, but there is some evidence that it is safe. Therefore, it received a score of 2."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger